Voloridge Investment Management
MYGN icon

Voloridge Investment Management’s Myriad Genetics MYGN Stock Holding History

Voloridge Investment Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-31,000
Closed -$165K – 1315
2025
Q2 		$165K Sell
31,000
-511,522
-94% -$3.02M ﹤0.01% 1129
2025
Q1 		$4.81M Buy
542,522
+423,301
+355% +$5.08M 0.02% 788
2024
Q4 		$1.63M Buy
+119,221
New +$2.2M 0.01% 972
2024
Q3 		– Sell
-84,660
Closed -$2.07M – 1296
2024
Q2 		$2.07M Sell
84,660
-2,051
-2% -$45K 0.01% 942
2024
Q1 		$1.85M Sell
86,711
-12,401
-13% -$267K 0.01% 873
2023
Q4 		$1.9M Buy
+99,112
New +$1.71M 0.01% 843
2021
Q3 		– Sell
-149,831
Closed -$4.58M – 1785
2021
Q2 		$4.58M Sell
149,831
-34,996
-19% -$1.01M 0.03% 677
2021
Q1 		$5.63M Buy
184,827
+41,148
+29% +$1.17M 0.04% 488
2020
Q4 		$2.84M Sell
143,679
-116,060
-45% -$1.87M 0.02% 622
2020
Q3 		$3.39M Sell
259,739
-247,131
-49% -$3.13M 0.03% 555
2020
Q2 		$5.75M Buy
506,870
+476,653
+1,577% +$6.77M 0.07% 319
2020
Q1 		$432K Buy
+30,217
New +$638K 0.01% 755
2019
Q1 		– Sell
-24,023
Closed -$698K – 1020
2018
Q4 		$698K Sell
24,023
-64,198
-73% -$2.31M 0.03% 304
2018
Q3 		$4.06M Buy
88,221
+131
+0.1% +$5.83K 0.09% 161
2018
Q2 		$3.29M Buy
+88,090
New +$2.98M 0.09% 217
2018
Q1 		– Sell
-36,710
Closed -$1.26M – 597
2017
Q4 		$1.26M Buy
+36,710
New +$1.24M 0.03% 355

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Voloridge Investment Management's MYGN Position: Q3 2025 in Review

Voloridge Investment Management sold out of Myriad Genetics (MYGN) in Q3 2025, closing a stake of 31,000 shares — an estimated $165K sold.

Voloridge Investment Management first reported a position in MYGN in Q4 2017 and held it in 16 quarters. The position peaked at $5.75M in Q2 2020. 221 funds tracked by Wall St. Rank hold MYGN as of Q3 2025.

  • Voloridge Investment Management reported no remaining Myriad Genetics position as of Q3 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 31,000 Myriad Genetics shares in Q3 2025, an estimated $165K.
  • Voloridge Investment Management first reported a position in Myriad Genetics in Q4 2017 and held it in 16 quarters.
  • Voloridge Investment Management's Myriad Genetics position peaked at $5.75M in Q2 2020.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2025.

Based on Voloridge Investment Management's 13F filing for Q3 2025, filed 14 Nov 2025.